Figure 2.

Observed mean HbA1c change from baseline to Week 18 (A), participants who achieved target HbA1c (B) and PPG levels (C) at Week 18. *P < .0001. Error bars: ± standard error of the mean. HbA1c targets: <7.0% (53.0 mmol/mol) and ≤6.5% (47.5 mmol/mol), and <7.0% (53.0 mmol/mol) and ≤6.5% (47.5 mmol/mol) without SH. PPG (based on SMPG) target: 2‐hour PPG ≤ 7.8 mmol/L (140 mg/dL) and 2‐hour PPG ≤7.8 mmol/L (140 mg/dL) without SH. Basal insulin: insulin detemir, insulin glargine U100 or NPH insulin. CI, confidence interval; faster aspart, fast‐acting insulin aspart; HbA1c, glycosylated haemoglobin; NPH, neutral protamine Hagedorn; OR, estimated odds ratio; PPG, postprandial plasma glucose; SH, severe hypoglycaemia during treatment period; SMPG, self‐measured plasma glucose. The conversion factor used for glucose between mmol/L and mg/dL was 0.0555